Latest news

September 2022
  • ​​Johanna Mariegaard, research assistant in the NEAD Group, wins a poster prize at the Annual Research Day for Mental Health Services, Capital Region of Denmark, 2022. Her poster was her MSc project on the neuronal underpinnings of picture encoding in patients with mood disorders and the effects of EPO on encoding-related neural activity. Congratulations, Johanna!​

​​March 2022
  • Professor Kamilla Miskowiak received a European Research Council (ERC) Consolidator Grant for her project ALTIBRAIN, in which she will investigate the effects of simulated altitude training on cognition and brain function. Read more (in Danish): here and here.
  • ​​Join the latest episode of “Videnskabens Veje" (in Danish), where you can hear Professor of Cognitive Neuropsychiatry Kamilla Miskowiak talk about EPO and the possible positive effects it can have on the cognitive functions of people with affective disorders​ here​.​​
October 2021

  • Professor Kamilla Miskowiak held her inaugural lecture as Full Professor of Cognitive Neuropsychiatry Friday 1st October 2021 – a joint position between Department of Psychology, University of Copenhagen, and the Mental Health Services, Capital Region of Denmark. It was a festive and inspiring afternoon!



  • Congratulations to Dr Anne Bjertrup who has been selected to speak at the "ECNP's Got Talent" session on the topic "Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder".
    The ECNP Excellence Award consists of a 100 EUR grant and a certificate as well as a 400 EUR travel grant for the ECNP congress in Lisbon, Portugal.
    The ECNP Congress 2021 will be a hybrid congress taking place Oct 2-5.
  • ​Congratulations also to Andreas Elleby Jespersen who has been awarded with the ECNP Excellence Award for his abstract "Cognition Assessment in Virtual Reality: Training of real-life cognitive functions with fully immersive virtual reality in mood or psychotic disorders".

July 2021
  • 12th July 2021: Professor Miskowiak has taken part in a TV interview about the cognitive sequelae after hospitalization with COVID-19 with Deutsche Welle – see the interview here  

    The interview is partly based on our study “Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables” published in European Neuropsychopharmacology, 2021: Link to article

February 2021
  • On the ECNP Early CareerScientist Workshop 2021 Dr. Anne Bjertrup present research on neural responses to own and unknown infant faces in mothers with bipolar disorder compared with healthy mothers. The background for this study is the emerging evidence that healthy motherhood is associated with structural and functional brain changes in regions important for rapid and sensitive processing of infant signals. However, bipolar disorder is, even in remission from affective episodes, associated with neurocognitive emotion processing difficulties reflected in brain structures overlapping with regions involved in processing of infant signals. Therefore, we investigated whether mothers with bipolar disorder compared with healthy mothers show different neural responses to images of own vs. unknown infant faces. We found that mothers with bipolar disorder showed reduced dorsolateral prefrontal cortex response to own vs. unknown infant faces compared with healthy mothers. This could indicate a less regulated neural response to watching own emotional infant faces, which could be related to less sensitive behavior toward the infant in mothers with bipolar disorder.

  • At the 2021 ECNP Workshop for Early Career Scientists in Europe, Dr. Hanne Lie Kjærstad presents research investigating cognitive predictors of mood episodes in newly diagnosed patients with bipolar disorder. The study is the first to investigate whether impairments in non-affective and affective cognition can predict the recurrence and duration of manic and depressive episodes, respectively, in a large sample of newly diagnosed patients with bipolar disorder during remission (n=144). Impairments in both non-affective and affective cognition predict the recurrence and duration of new manic – but not depressive – episodes. This suggests that early prophylactic strategies targeting cognitive impairments may increase resilience in newly diagnosed patients with bipolar disorder. 

January 2021
  • Our recent study “Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression” published in European Neuropsychopharmacology was selected as Editor’s choice in January 2021. See the comment here

December 2020

  • Congratulations to Hanne Lie Kjærstad for being awarded 600.000 DKK from Region Hovedstadens Forskningsfond til Sundhedsforskning 2020 for the postdoc project "Prediction of risk and resilience in bipolar disorder: what can neuroimaging and neurocognitive biomarkers tell us? (PREDICT)". 

November 2020

  • Congratulations to Hanne Lie Kjærstad for receiving Region Hovedstadens Psykiatri Postdoc grant of 1.687.000 DKK for the project “Prediction of risk and resilience in bipolar disorder: what can neuroimaging and neurocognitive biomarkers tell us? (PREDICT)”. 

December 2019

  • NEAD group Christmas symposium about risk in psychiatry and clinical trials, December 2019

May 2019
  • Click here to read the Lundbeckfonden News article, "Topforsker - med baby på armen", which includes an interview with Professor Kamilla Miskowiak.

November 2018
October 2018
  • The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force chaired by Professor Miskowiak has developed a patient booklet with information about the nature of cognitive dysfunction in patients with bipolar disorder and a practical guide on how to facilitate cognitive capacity and compensate for cognitive problems in daily life (

    Click below to access the booklet and read more about why, when, and how to assess and address cognition in these patients.

    English version:

    Danish version:

June 2018
  • NEAD Group was well represented among poster presenters at the annual Psychiatric Research Day ("Region Hovedstadens Psykiatris Forskningsdag"), which took place at Rigshospitalet, Copenhagen,
    Denmark on the 27th of June 2018.

​In t​he ​news

Interna​tional and national media coverage of our research

January 2018

  • Professor Kamilla Woznica Miskowiak defended her doctoral dissertation and was awarded the doctoral degree in medical science ( on Thursday 11th of January 2018. Click here to read more.

July 2017
June 2017
  • European Psychiatric Association (EPA)

  • Watch Professor Kamilla Miskowiak giving an interview to at the EPA in 2017. 

  • Lundbeckfonden Magazine 2017

  • The Lundbeckfonden Magazine 2017 includes an interview with Dr Kamilla Miskowiak about the PRETEC-Marker studies. The magazine is available online. Click here to read the interview, "Research paves the way for novel treatment for concentration difficulties" (p. 24-27) 

lundbeckfondenmagazine2017 v1.jpg

February 2017

  • Radio interview

  • Dr Kamilla Miskowiak’s interview about electroconvulsive therapy and cognition on the national Danish radio, P1, 31st January 2017. Click here to listen to the broadcast.

November 2016
  • Lundbeckfonden Fellowship

  • Dr Kamilla Miskowiak is one of the new Lundbeckfonden Fellows 2016. The fellowship of 10 million DKK (1.34 million Euro) enables her to conduct a large neuroimaging project that aims to identify a novel brain-based biomarker model for pro-cognitive effects. A biomarker model that can help select among new candidate cognition treatments prior to large-scale clinical efficacy trials. The project may lead to a break-through in development of treatments for cognitive impairment in psychiatric disorders.

    See a 2 minute film about the project here:

​​​September 2016
  • See the latest international news about our EPO research based on a poster that was presented at the European College of Neuropsychopharmacology (ECNP) meeting in Vienna Sep 2016:

EPO boosts cognition in depressed and bipolar patients​ (Genetic Engineering & Biotechnology News)

EPO-Doping bei Depressionen​ (bild der wissenschaft)

July 2016
  • Video podcast with Dr Kamilla Miskowiak telling about EPO-associated memory improvement in mood disorders (Acta Psychiatrica Scandinavica) 

Other news

Doping hormone helps depressed remember better​ (ScienceNordic)

NeuroScene podcast interview with Dr Kamilla Miskowiak: Erythropoietin: A New Compound for Depression?
In Danish:

EPO giver depressive bedre hukommelse (
EPO ser ud til at have antidepressiv effekt​ (
Dopingmiddel kan hjælpe depressive (
EPO styrker hukommelsen hos mennesker med depression (Mental health services in the Capital Region of Denmark)
Forskning i følelser vinder frem
(Interview with Dr Kamilla Miskowiak about emotion research in the national Danish newspaper Kristeligt Dagblad)
Radio interview with Dr Kamilla Miskowiak in Danish about gender bias in science after she was given the L’Oréal For Women in Science award; fast forward to 31 minutes into the program